Risk of Primary and Recurrent Acute Myocardial Infarction From Lipoprotein(a) in Men and Women11This study was supported by grants from the National Heart Foundation of Australia, National Health and Medical Research Council of Australia, Newcastle.

This publication has 25 references indexed in Scilit:

• Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men
  JAMA, 1994
• Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study
  Atherosclerosis, 1993
• Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population
  Atherosclerosis, 1993
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants
  Atherosclerosis, 1991
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
  BMJ, 1990
• Lipoprotein(a), fibrin binding, and plasminogen activation.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• The Mysteries Of Lipoprotein(a)
  Science, 1989
• A potential basis for the thrombotic risks associated with lipoprotein(a)
  Nature, 1989
• Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
  Nature, 1989
• Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
  Circulation, 1986